Renal Thrombotic Microangiopathy after Hematopoietic Cell Transplant | Zendy

Siribha Changsirikulchai | Zendy; David Myerson | Zendy; Katherine A. Guthrie | Zendy; George B. McDonald | Zendy; Charles E. Alpers | Zendy; Sangeeta Hingorani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Renal Thrombotic Microangiopathy after Hematopoietic Cell Transplant

Author(s) -

Siribha Changsirikulchai,

David Myerson,

Katherine A. Guthrie,

George B. McDonald,

Charles E. Alpers,

Sangeeta Hingorani

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02070508

Subject(s) - thrombotic microangiopathy , medicine , microangiopathic hemolytic anemia , thrombotic thrombocytopenic purpura , transplantation , acute kidney injury , population , gastroenterology , kidney transplantation , schistocyte , kidney , hematopoietic stem cell transplantation , disease , platelet , environmental health

Thrombotic microangiopathy (TMA) is a known complication of hematopoietic cell transplantation (HCT). The etiology and diagnosis of TMA in this patient population is often difficult because thrombocytopenia, microangiopathic hemolytic anemia, and kidney injury occur frequently in HCT recipients, and are the result of a variety of insults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research